Determining the appropriate retatrutide dosage is critically important for achieving best outcomes . Initially, individuals typically commence with a modest dose of approximately 2.4 mg, given each week via subcutaneous . This initial quantity is then progressively increased every four periods, up to a peak amount of 10.8 mg, based on individual r